Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
86
VCYT Quote, Financials, Valuation and Earnings
Last price:
$47.41
Seasonality move
:
1.88%
Day range:
$46.02 - $47.78
52-week range:
$22.61 - $50.71
Dividend yield:
0%
P/E ratio:
125.79x
P/S ratio:
7.67x
P/B ratio:
3.00x
Volume:
1.1M
Avg. volume:
1M
1-year change:
9.37%
Market cap:
$3.8B
Revenue:
$445.8M
EPS (TTM):
$0.38
Analysts' Opinion
-
Consensus RatingVeracyte, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 2 Hold ratings, and 1 Sell rating.
-
Price Target DownsideAccording to analysts' consensus price target of $47.10, Veracyte, Inc. has an estimated downside of -1.36% from its current price of $47.75.
-
Price Target UpsideAccording to analysts, the highest upside price target is $53.00 representing 11% upside increase from its current price of $47.75.
Fair Value
-
According to the consensus of 11 analysts, Veracyte, Inc. has -1.36% downside to fair value with a price target of $47.10 per share.
VCYT vs. S&P 500
-
Over the past 5 trading days, Veracyte, Inc. has underperformed the S&P 500 by -3.31% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Veracyte, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Veracyte, Inc. has grown year-over-year revenues for 21 quarters straight. In the most recent quarter Veracyte, Inc. reported revenues of $131.9M.
Earnings Growth
-
Veracyte, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Veracyte, Inc. reported earnings per share of $0.24.
Enterprise value:
3.4B
EV / Invested capital:
2.66x
Price / LTM sales:
7.67x
EV / EBIT:
69.77x
EV / Revenue:
6.96x
PEG ratio (5yr expected):
-0.48x
EV / Free cash flow:
35.11x
Price / Operating cash flow:
38.66x
Enterprise value / EBITDA:
48.03x
Gross Profit (TTM):
$331M
Return On Assets:
2.28%
Net Income Margin (TTM):
6.12%
Return On Equity:
2.52%
Return On Invested Capital:
2.43%
Operating Margin:
17.53%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $343.1M | $425.3M | $495.1M | $115.9M | $131.9M | |
| Gross Profit | $207.5M | $276.2M | $331M | $76.7M | $89.4M | |
| Operating Income | -$13M | $11.3M | $49.4M | $12.2M | $23.1M | |
| EBITDA | $17.2M | $34.8M | $71.8M | $18.1M | $28.4M | |
| Diluted EPS | -$0.69 | -$0.14 | $0.38 | $0.19 | $0.24 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $229.3M | $238.5M | $271.2M | $356.9M | $449.2M | |
| Total Assets | $1.2B | $1.1B | $1.1B | $1.3B | $1.4B | |
| Current Liabilities | $50M | $58.4M | $57.3M | $70.3M | $72.2M | |
| Total Liabilities | $79.3M | $77.8M | $70.9M | $99M | $110.1M | |
| Total Equity | $1.1B | $1B | $1.1B | $1.2B | $1.3B | |
| Total Debt | $15.3M | $12.7M | $8.7M | $12.4M | $36.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $38.4M | $66.1M | $108.2M | $30M | $44.8M | |
| Cash From Investing | -$8.8M | -$4.6M | -$57.9M | -$2.2M | $48.3M | |
| Cash From Financing | $2.3M | $10.1M | -$8.6M | $10.3M | $3M | |
| Free Cash Flow | $29.1M | $56.5M | $98.2M | $27.7M | $42M | |
VCYT
Sector
Market Cap
$3.8B
$28.4M
Price % of 52-Week High
94.16%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-0.66%
-1.32%
1-Year Price Total Return
9.37%
-22.19%
Beta (5-Year)
1.829
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$46.93
200-day SMA
Buy
Level
$31.78
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$43.51
Relative Strength Index (RSI14)
Buy
Level
64.99
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-23.2522
50-day SMA
Buy
Level
$38.51
MACD (12, 26)
Buy
Level
2.71
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
--
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (11.9059)
Buy
CA Score
(Annual)
Level (1.6252)
Buy
Beneish M-Score
(Annual)
Level (-2.613)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-4.7969)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Stock Forecast FAQ
In the current month, VCYT has received 8 Buy ratings 2 Hold ratings, and 1 Sell ratings. The VCYT average analyst price target in the past 3 months is $47.10.
-
Where Will Veracyte, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Veracyte, Inc. share price will drop to $47.10 per share over the next 12 months.
-
What Do Analysts Say About Veracyte, Inc.?
Analysts are divided on their view about Veracyte, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Veracyte, Inc. is a Sell and believe this share price will rise from its current level to $43.00.
-
What Is Veracyte, Inc.'s Price Target?
The price target for Veracyte, Inc. over the next 1-year time period is forecast to be $47.10 according to 11 Wall Street analysts, 8 of them rate the stock a Buy, 1 rates the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is VCYT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Veracyte, Inc. is a Buy. 8 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of VCYT?
You can purchase shares of Veracyte, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Veracyte, Inc. shares.
-
What Is The Veracyte, Inc. Share Price Today?
Veracyte, Inc. was last trading at $47.41 per share. This represents the most recent stock quote for Veracyte, Inc.. Yesterday, Veracyte, Inc. closed at $47.75 per share.
-
How To Buy Veracyte, Inc. Stock Online?
In order to purchase Veracyte, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get VCYT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VCYT
Sector
P/E ratio
125.79x
23.66x
PEG ratio
-0.48x
-0.01x
P/B ratio
3.00x
1.84x
Price / LTM sales
7.67x
1.60x
Growth Metrics
VCYT
Sector
Revenue growth
13.82%
4.85%
Earnings growth
24.34%
11.15%
Revenue (5-year growth)
29.93%
6.45%
Earnings forecast
$0.32
-$0.20
Profitability
VCYT
Sector
Profitability FY 2024
$289.5M
$3.6M
Return on invested capital
2.43%
-30.98%
Return on assets
2.28%
-27.62%
Return on equity
2.52%
-36.69%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
24
Estimated Next Earnings Date
Feb
3
Balance Sheet
VCYT
Sector
Total cash
$366.4M
$27.2M
Short term investments
$50.4M
$25.7M
Total assets
$1.3B
$79.9M
Long term debt
$36.2M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
64
Is AAPL Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
